Efficacy, Safety, Tolerability, and Pharmacokinetics of TrIP Administered to Subjects With Chronic Obstructive Pulmonary Disease.

Trial Profile

Efficacy, Safety, Tolerability, and Pharmacokinetics of TrIP Administered to Subjects With Chronic Obstructive Pulmonary Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Aug 2011

At a glance

  • Drugs Trospium chloride (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 18 May 2010 Results have been presented at the 106th International Conference of the American Thoracic Society.
    • 08 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Feb 2009 Top-line results from the full study are expected in the second half of 2009 according to an Alkermes media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top